作者
K Allegaert, R Verbesselt, G Naulaers, JN Van Den Anker, M Rayyan, A Debeer, J De Hoon
发表日期
2008/2/1
来源
Acta Clinica Belgica
卷号
63
期号
1
页码范围
16-24
出版商
Taylor & Francis
简介
Neonatal drug dosing needs to be based on the physiological characteristics of the newborn and the pharmacokinetic parameters of the drug. Size-related changes can in part be modelled based on allometry and relates to the observation that metabolic rate relates to weight by a kg0.75 trend. Until adult metabolic activity has been reached, ontogeny, i.e. isoenzyme-specific maturation and maturation of renal clearance also contributes to drug metabolism, making isoenzyme-specific documentation of maturation necessary.
Changes in body composition and ontogeny are most prominent in neonates. The body fat content (/kg) is markedly lower and the body water content (/kg) is markedly higher in neonates. These findings have an impact on the distribution volume of both lipophilic and hydrophilic drugs. Drugs are cleared either by metabolism or elimination. While the first is mainly hepatic, the second route is …
引用总数
200820092010201120122013201420152016201720182019202020212022202320241111013714126115937243
学术搜索中的文章